| KRAS altered in cohorts of …ALTERED_INderived23 of 23show fewer |
|---|
| → altered in cohorts of | Testicular Germ Cell Tumor 255 / 263 cases (97 %) · ssm · TCGA-TGCT | — | — | Testicular Germ Cell Tumor | 1 | Observed | gdc | graph → |
| → altered in cohorts of | Appendix Adenocarcinoma 161 / 273 cases (59 %) · ssm · appendiceal_msk_2022 | — | — | Appendix Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Ampulla of Vater Carcinoma 86 / 160 cases (54 %) · ssm · ampca_bcm_2016 | — | — | Ampulla of Vater Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Colorectal Adenocarcinoma 495 / 1,134 cases (44 %) · ssm · crc_msk_2017 · largest of 14 cohorts | — | — | Colorectal Adenocarcinoma | 14 | Observed | cbioportal | graph → |
| → altered in cohorts of | Rectal Adenocarcinoma 3,096 / 7,237 cases (43 %) · ssm · crc_msk_2026 · largest of 2 cohorts | — | — | Rectal Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Colon Adenocarcinoma 183 / 429 cases (43 %) · ssm · coad_tcga_gdc · largest of 4 cohorts | — | — | Colon Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Pancreatic Adenocarcinoma 168 / 412 cases (41 %) · ssm · pancreas_ctdna_msk_2025 · largest of 10 cohorts | — | — | Pancreatic Adenocarcinoma | 10 | Observed | cbioportal | graph → |
| → altered in cohorts of | Low-Grade Serous Ovarian Cancer 38 / 119 cases (32 %) · ssm · lgsoc_mapk_msk_2022 | — | — | Low-Grade Serous Ovarian Cancer | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Adenocarcinomasubtype 787 / 2,653 cases (30 %) · ssm · luad_mskcc_2023_met_organotropism · largest of 13 cohorts | — | — | Lung Adenocarcinoma | 13 | Observed | cbioportal | graph → |
| → altered in cohorts of | Endometrial Endometrioid Adenocarcinoma 67 / 247 cases (27 %) · ssm · uec_cptac_gdc | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Multiple Myelomahematologic_malignancy 227 / 961 cases (24 %) · ssm · MMRF-COMMPASS · largest of 2 cohorts | — | — | Multiple Myeloma | 2 | Observed | gdc | graph → |
| → altered in cohorts of | Lung Non-Small Cell Carcinomasubtype 523 / 2,621 cases (20 %) · ssm · nsclc_ctdx_msk_2022 · largest of 6 cohorts | — | — | Lung Non-Small Cell Carcinoma | 6 | Observed | cbioportal | graph → |
| → altered in cohorts of | Endometrial Carcinoma 357 / 1,882 cases (19 %) · ssm · ucec_ancestry_cds_msk_2023 · largest of 8 cohorts | — | — | Endometrial Carcinoma | 8 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cholangiocarcinoma 76 / 417 cases (18 %) · ssm · chol_icgc_2017 · largest of 2 cohorts | — | — | Cholangiocarcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Non-Seminomatous Germ Cell Tumor 20 / 155 cases (13 %) · ssm · tgct_tcga | — | — | Non-Seminomatous Germ Cell Tumor | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Acute Lymphoblastic Leukemia 97 / 768 cases (13 %) · ssm · TARGET-ALL-P2 | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | gdc | graph → |
| → altered in cohorts of | B Lymphoblastic Leukemia/Lymphoma 90 / 739 cases (12 %) · ssm · bll_target_gdc | — | — | B Lymphoblastic Leukemia/Lymphoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Hepatocellular Carcinomasubtype 152 / 1,370 cases (11 %) · ssm · hcc_msk_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Intrahepatic Cholangiocarcinoma 39 / 412 cases (9.5 %) · ssm · ihch_msk_2021 | — | — | Intrahepatic Cholangiocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Gastroesophageal Junction Adenocarcinoma 31 / 341 cases (9.1 %) · ssm · egc_msk_2017 | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Acute Myeloid Leukemia 78 / 887 cases (8.8 %) · ssm · aml_stjude_2024 · largest of 2 cohorts | — | — | Acute Myeloid Leukemia | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Histiocytic and Dendritic Cell Neoplasm 102 / 1,270 cases (8.0 %) · ssm · hdcn_msk_2025 | — | — | Histiocytic and Dendritic Cell Neoplasm | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Gastric Adenocarcinoma 37 / 478 cases (7.7 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |